Supply Agreements in the Pharmaceuticals Industry
435 Contracts & Agreements
- Acacia Diversified Holdings, Inc. (2 contracts)
- Accelerated Pharma, Inc. (1)
- ACELRX PHARMACEUTICALS INC (3)
- Aclaris Therapeutics, Inc. (3)
- Adamis Pharmaceuticals Corp (1)
- AERIE PHARMACEUTICALS INC (6)
- Alexza Pharmaceuticals Inc. (1)
- Altus Pharmaceuticals Inc. (8)
- Amag Pharmaceuticals (8)
- Amphastar Pharma (7)
- Ampio Pharmaceuticals, Inc. (1)
- AMYLIN PHARMACEUTICALS INC (16)
- Amylyx Pharmaceuticals, Inc. (2)
- Angion Biomedica Corp. (1)
- ANGIOTECH PHARMACEUTICALS INC (2)
- Aquestive Therapeutics, Inc. (4)
- ARADIGM CORP (2)
- Aralez Pharmaceuticals Inc. (1)
- ARIAD PHARMACEUTICALS INC (1)
- Artemis Therapeutics, Inc. (1)
- Assertio Holdings, Inc. (1)
- Assertio Therapeutics, Inc (5)
- Astex Pharmaceuticals, Inc (2)
- AUXILIUM PHARMACEUTICALS INC (3)
- AVADEL PHARMACEUTICALS PLC (2)
- AYTU BIOSCIENCE, INC (1)
- Bausch Health Companies Inc. (1)
- BIODELIVERY SCIENCES INTERNATIONAL INC (2)
- BioNumerik Pharmaceuticals, Inc. (5)
- BioPharmX Corp (1)
- CADENCE PHARMACEUTICALS INC (3)
- Cancer Prevention Pharmaceuticals, Inc. (3)
- CANNAPHARMARX, INC. (2)
- Cara Therapeutics, Inc. (1)
- CARDAX, INC. (1)
- CERAGENIX PHARMACEUTICALS, INC. (1)
- Citius Pharmaceuticals, Inc. (2)
- Clearside Biomedical, Inc. (1)
- Cocrystal Pharma, Inc. (2)
- Corcept Therapeutics Incorporated (5)
- CorMedix Inc. (1)
- CUBIST PHARMACEUTICALS INC (7)
- CUMBERLAND PHARMACEUTICALS INC (7)
- Dermata Therapeutics, Inc. (1)
- Dova Pharmaceuticals Inc. (1)
- DURECT CORP (1)
- Egalet Corp (2)
- Elanco Animal Health Inc (2)
- ELITE PHARMACEUTICALS INC (5)
- Eloxx Pharmaceuticals, Inc. (2)
- Endo International plc (3)
- Endo Pharmaceuticals Solutions Inc. (1)
- Evofem Biosciences, Inc. (1)
- Evolus, Inc. (4)
- Exactus, Inc. (1)
- EyePoint Pharmaceuticals, Inc. (1)
- Foamix Pharmaceuticals Ltd. (1)
- GridIron BioNutrients, Inc. (2)
- Horizon Pharma plc (30)
- IMMTECH PHARMACEUTICALS, INC. (1)
- Innoviva, Inc. (2)
- INSPIRE PHARMACEUTICALS INC (1)
- Intersect ENT, Inc. (8)
- Intra-Cellular Therapies, Inc. (4)
- Jaguar Health, Inc. (5)
- JAVELIN PHARMACEUTICALS, INC (1)
- Jazz Pharmaceuticals plc (12)
- JUNIPER PHARMACEUTICALS INC (5)
- Kala Pharmaceuticals, Inc. (4)
- KEMPHARM, INC (2)
- KING PHARMACEUTICALS INC (1)
- KOS PHARMACEUTICALS INC (1)
- Lannett Company, Inc. (5)
- Lev Pharmaceuticals Inc (2)
- Lipocine Inc. (1)
- Liquidia Corp (6)
- MARINUS PHARMACEUTICALS INC (1)
- MICROCHANNEL TECHNOLOGIES CORP (1)
- MiddleBrook Pharmaceuticals, Inc. (2)
- Molecular Insight Pharmaceuticals, Inc. (2)
- MYnd Analytics, Inc. (2)
- Nabriva Therapeutics plc (9)
- Neos Therapeutics, Inc. (1)
- NEW RIVER PHARMACEUTICALS INC (1)
- Notis Global, Inc. (1)
- NOVEN PHARMACEUTICALS INC (2)
- OMEROS CORP (6)
- Omthera Pharmaceuticals, Inc. (3)
- OPIANT PHARMACEUTICALS, INC. (1)
- OPTIMER PHARMACEUTICALS INC (8)
- OptiNose, Inc. (4)
- OSI PHARMACEUTICALS INC (2)
- Pacira Pharmaceuticals, Inc. (10)
- Paratek Pharmaceuticals, Inc. (16)
- Phathom Pharmaceuticals, Inc. (8)
- POLYDEX PHARMACEUTICALS LTD (1)
- PONIARD PHARMACEUTICALS, INC. (3)
- Prestige Brands Holdings Inc (5)
- Pulmatrix, Inc. (2)
- QUESTCOR PHARMACEUTICALS INC (1)
- Recro Pharma, Inc. (3)
- Reliant Pharmaceuticals, Inc. (1)
- Revance Therapeutics, Inc. (1)
- Roivant Sciences Ltd. (3)
- Sagent Pharmaceuticals, Inc. (2)
- SALIX PHARMACEUTICALS LTD (13)
- SAVIENT PHARMACEUTICALS INC (1)
- SCICLONE PHARMACEUTICALS INC (3)
- scPharmaceuticals Inc. (1)
- Sonoma Pharmaceuticals, Inc. (7)
- Sucampo Pharmaceuticals, Inc. (4)
- Supernus Pharmaceuticals, Inc. (2)
- TETRAPHASE PHARMACEUTICALS INC (1)
- The Medicines Company (4)
- TherapeuticsMD, Inc. (6)
- Theravance Biopharma, Inc. (4)
- Tilray, Inc. (1)
- Tribute Pharmaceuticals Canada Inc. (1)
- Tricida, Inc. (4)
- Upjohn Inc (2)
- Urovant Sciences Ltd. (2)
- Valera Pharmaceuticals Inc (1)
- VIVUS INC (8)
- XANODYNE PHARMACEUTICALS INC (2)
- Xeris Biopharma Holdings, Inc. (1)
- XERIS PHARMACEUTICALS INC (7)
- Zoetis (1)
- ZOGENIX, INC. (6)
- Zomedica Pharmaceuticals Corp. (2)
- Supply Agreement, dated May 22, 2023, by and between Liquidia Technologies, Inc. and Plastiape SpA (Liquidia Corp, Filed With SEC on March 13, 2024)
- Amended and Restated Commercial Manufacturing Services and Supply Agreement, dated July 13, 2023, by and between Liquidia Technologies, Inc. and Lonza Tampa LLC (Liquidia Corp, Filed With SEC on March 13, 2024)
- Third Amendment to Supply Agreement, dated as of April 12, 2023, by and between Spectrum and Hanmi Pharmaceuticals Co., Ltd (Assertio Holdings, Inc., Filed With SEC on March 11, 2024)
- First Amendment to the Commercial Supply Agreement, dated as of December 6, 2023, by and among Catalent Pharma Solutions, LLC and the Registrant (Phathom Pharmaceuticals, Inc., Filed With SEC on March 7, 2024)
- Third Amendment to Manufacturing and Supply Agreement dated December 1, 2023, by and between the Registrant and Patheon UK Limited (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
- Second Amendment to Manufacturing and Supply Agreement dated June 17, 2019, between Flexion Therapeutics, Inc. and Patheon UK Limited (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
- First Amendment to Manufacturing and Supply Agreement dated May 8, 2019, between Flexion Therapeutics, Inc. and Patheon UK Limited (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
- Generic API Supply Agreement (AVADEL PHARMACEUTICALS PLC, Filed With SEC on February 29, 2024)
- Supply Agreement between CannaPharmaRX, Inc. and D.N.S. Cantek 2019 Ltd dated February 12, 2024 (CANNAPHARMARX, INC., Filed With SEC on February 22, 2024)
- Supply Agreement between CannaPharmaRX, Inc. and D.N.S. Cantek 2019 Ltd dated February 12, 2024 (CANNAPHARMARX, INC., Filed With SEC on February 16, 2024)
- Fourth Amended and Restated Wholesale Cannabis Supply Agreement, dated as of January 5, 2024, by and between 1974568 Ontario Limited and Aphria Inc (Tilray, Inc., Filed With SEC on January 9, 2024)
- Amendment No. 1, dated December 18, 2023, to Supply Agreement, dated July 1, 2017, between OptiNose US, Inc. and Hovione Inter Ltd (OptiNose, Inc., Filed With SEC on December 21, 2023)
- First Amendment to BAW Sensor Supply Agreement (Zomedica Pharmaceuticals Corp., Filed With SEC on October 10, 2023)
- Amendment No. 1 to Manufacturing and Supply Agreement, dated July 12, 2023, by and between Napo Pharmaceuticals, Inc. and Glenmark Life Sciences Limited (Jaguar Health, Inc., Filed With SEC on August 14, 2023)
- Amended and Restated Commercial Manufacturing Services and Supply Agreement, dated July 13, 2023, by and between Liquidia Technologies, Inc. and Lonza Tampa LLC (Liquidia Corp, Filed With SEC on August 10, 2023)
- Supply Agreement, dated May 22, 2023, by and between Liquidia Technologies, Inc. and Plastiape SpA (Liquidia Corp, Filed With SEC on August 10, 2023)
- First Amendment to Vonoprazan Commercial Supply Agreement (Phathom Pharmaceuticals, Inc., Filed With SEC on August 10, 2023)
- Commercial Supply Agreement, dated as of August 8, 2023, by and between the Registrant and ICE S.p.A. (formerly Prodotti Chimici e Alimentari S.p.A.) (Amylyx Pharmaceuticals, Inc., Filed With SEC on August 10, 2023)
- Fifth Amendment to Supply Agreement, dated as of April 20, 2023, by and between Daewoong Pharmaceutical Co. Ltd. and Evolus, Inc (Evolus, Inc., Filed With SEC on August 2, 2023)
- Side Letter dated June 5, 2023, to the Manufacturing and Supply Agreement by and between the Registrant and Patheon UK Limited (Pacira Pharmaceuticals, Inc., Filed With SEC on August 2, 2023)
- Commercial Supply Agreement, dated May 17, 2023, by and between EyePoint Pharmaceuticals, Inc. and Alimera Sciences, Inc (EyePoint Pharmaceuticals, Inc., Filed With SEC on May 18, 2023)
- First Amendment, effective as of January 1, 2023, to the Supply Agreement, dated as of October 29, 2019, by and between the Registrant and CU Chemie Uetikon GmbH (Amylyx Pharmaceuticals, Inc., Filed With SEC on May 11, 2023)
- Third Amendment to API Supply Agreement, dated November 11, 2022, by and between Nabriva Therapeutics Ireland Designated Activity Company and Hovione Limited (Nabriva Therapeutics plc, Filed With SEC on April 17, 2023)
- Generic API Supply Agreement by and between Euticals Inc. and Avadel CNS Pharmaceuticals, LLC, dated as of January 2, 2020 (AVADEL PHARMACEUTICALS PLC, Filed With SEC on March 29, 2023)
- Supply Agreement dated as of January 5, 2023 by and between Siegfried AG and the Registrant (Intra-Cellular Therapies, Inc., Filed With SEC on March 1, 2023)
- Exclusive Distribution and Supply Agreement, dated January 26, 2023, by and between Sonoma Pharmaceuticals, Inc. and Daewoong Pharmaceutical Co., Ltd (Sonoma Pharmaceuticals, Inc., Filed With SEC on January 31, 2023)
- BAW Sensor Supply Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp (Zomedica Pharmaceuticals Corp., Filed With SEC on January 24, 2023)
- Fourth Amendment to Supply Agreement, dated December 12, 2022, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Evolus, Inc., Filed With SEC on December 13, 2022)
- Supply Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc. and Nanjing Letop Biotechnology Co., Ltd. dated November 15, 2022 (Amphastar Pharma, Filed With SEC on November 18, 2022)
- Master Commercial Manufacturing Supply Agreement, dated as of July 1, 2022, by and between Dermavant Sciences GmbH and Thermo Fisher Scientific Cork Limited (Roivant Sciences Ltd., Filed With SEC on November 14, 2022)
- Amendment No. 1 Clinical and Commercial Manufacturing and Supply Agreement, dated as of January 18, 2018, by and between Jazz Pharmaceuticals Ireland Limited and Baxter Oncology... (Jazz Pharmaceuticals plc, Filed With SEC on November 9, 2022)
- Clinical and Commercial Manufacturing and Supply Agreement, dated as of December 22, 2010, between Celator Pharmaceuticals, Inc. and Baxter Oncology GmbH (Jazz Pharmaceuticals plc, Filed With SEC on November 9, 2022)
- Commercial Supply Agreement with Evonik Operations GmbH entered into on August 1, 2022 (Phathom Pharmaceuticals, Inc., Filed With SEC on November 8, 2022)
- Second Amendment to API Supply Agreement, dated as of May 2, 2022, by and between (Xeris Biopharma Holdings, Inc., Filed With SEC on August 10, 2022)
- Amendment No. 4 to Commercial Supply Agreement, dated May 31, 2022, by and between AGC Biologics A/S (formerly known as CMC Biologics A/S) and Horizon Therapeutics Ireland DAC (Horizon Pharma plc, Filed With SEC on August 3, 2022)
- Supply Agreement between Manuka Ltd. and Waitemata Honey Co. Ltd., dated July 20, 2021 (Artemis Therapeutics, Inc., Filed With SEC on July 5, 2022)
- Manufacture and Supply Agreement by and between Chartwell Pharmaceuticals Carmel, LLC, Chartwell Pharmaceuticals LLC, and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on May 10, 2022)
- Renewal to the Manufacture and Supply Agreement, dated as of January 3, 2022, by and between Cayman Chemical Company, Incorporated and Aerie Distribution, Incorporated (AERIE PHARMACEUTICALS INC, Filed With SEC on May 6, 2022)
- Cultivation and Supply Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on May 4, 2022)
- Supply Agreement, dated December 10, 2022, by and between Angion Biomedica Corp. and Solara Active Pharma Sciences, Ltd (Angion Biomedica Corp., Filed With SEC on March 30, 2022)
